Published in Cancer Res on April 01, 1994
Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol (2002) 3.82
Molecular classification of gastric cancer: a new paradigm. Clin Cancer Res (2011) 2.00
Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice. Gut (2004) 1.34
Microsatellite instability in gastric intestinal metaplasia in patients with and without gastric cancer. Am J Pathol (2000) 1.20
Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma. Am J Pathol (2002) 1.12
Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance. World J Gastroenterol (2004) 1.04
Low frequency of HER2 amplification and overexpression in early onset gastric cancer. Cell Oncol (Dordr) (2011) 1.02
The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": a study of the TGFbeta RII, IGFII R, and BAX genes. Am J Pathol (1998) 1.00
Clinical characteristics and outcomes for gastric cancer patients aged 18-30 years. Gastric Cancer (2014) 1.00
Plasma and dietary carotenoid, retinol and tocopherol levels and the risk of gastric adenocarcinomas in the European prospective investigation into cancer and nutrition. Br J Cancer (2006) 0.99
Trend in incidence of gastric adenocarcinoma by tumor location from 1969-2004: a study in one referral center in Iran. Diagn Pathol (2006) 0.99
Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells. J Clin Invest (1998) 0.98
Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer. Br J Cancer (2008) 0.95
Cancer stem cell hypothesis and gastric carcinogenesis: Experimental evidence and unsolved questions. World J Gastrointest Oncol (2012) 0.95
The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with a cardiac location. Mol Pathol (2000) 0.94
Acute WNT signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formation. Oncogene (2012) 0.93
Gastric cancer: pathogenesis, risks, and prevention. J Gastroenterol (2002) 0.93
High frequency of microsatellite instability in intestinal-type gastric cancer in Korean patients. Korean J Intern Med (2005) 0.90
Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma--a population-based study in Sweden. Br J Cancer (2000) 0.88
Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms. World J Gastroenterol (2006) 0.86
Analysis of cell damage and proliferation in Helicobacter pylori-infected human gastric mucosa from patients with gastric adenocarcinoma. Am J Pathol (1997) 0.85
Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer. J Cancer Res Clin Oncol (2003) 0.85
Gastric cancer in young people under 30 years of age: worse prognosis, or delay in diagnosis? Cancer Manag Res (2013) 0.84
A regulatory polymorphism at position -309 in PTPRCAP is associated with susceptibility to diffuse-type gastric cancer and gene expression. Neoplasia (2009) 0.83
Fish consumption and the risk of gastric cancer: systematic review and meta-analysis. BMC Cancer (2011) 0.82
Fluorescence in situ hybridisation analysis of chromosomal aberrations in gastric tissue: the potential involvement of Helicobacter pylori. Br J Cancer (2005) 0.82
K-ras mutations and cell kinetics in Helicobacter pylori associated gastric intestinal metaplasia: a comparison before and after eradication in patients with chronic gastritis and gastric cancer. J Clin Pathol (2006) 0.81
Expression of CDC25 phosphatases in human gastric cancer. Dig Dis Sci (2007) 0.81
Expression of 1A6 gene and its correlation with intestinal gastric carcinoma. World J Gastroenterol (2003) 0.81
Expression of mutant type-p53 products in H pylori-associated chronic gastritis. World J Gastroenterol (2007) 0.80
p53 and p14 increase sensitivity of gastric cells to H. pylori-induced apoptosis. Dig Dis Sci (2003) 0.80
Mitochondrial microsatellite instability in gastric cancer and its precancerous lesions. World J Gastroenterol (2004) 0.80
Poorly differentiated adenocarcinoma with signet-ring cell carcinoma in a hyperplastic polyp of the stomach: report of a case. Surg Today (2007) 0.79
Analysis of p53 mutations and Helicobacter pylori infection in human and animal models. J Gastroenterol (2002) 0.79
Selective fraction of Atractylodes lancea (Thunb.) DC. and its growth inhibitory effect on human gastric cancer cells. Cytotechnology (2013) 0.78
Expression and significance of p53 and mdm2 in atypical intestinal metaplasia and gastric carcinoma. Oncol Lett (2011) 0.78
Pathology and cost effectiveness of endoscopy surveillance for premalignant gastric lesions. Gut (2003) 0.78
Early-onset gastric cancer: Learning lessons from the young. World J Gastrointest Oncol (2010) 0.78
Prohormone convertase furin has a role in gastric cancer cell proliferation with parathyroid hormone-related peptide in a reciprocal manner. Dig Dis Sci (2002) 0.78
Effects of folic acid on epithelial apoptosis and expression of Bcl-2 and p53 in premalignant gastric lesions. World J Gastroenterol (2005) 0.78
First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile. Virchows Arch (2013) 0.77
MUC5AC upstream complex repetitive region length polymorphisms are associated with susceptibility and clinical stage of gastric cancer. PLoS One (2014) 0.76
An inverse relationship between the expression of the gastric tumor suppressor RUNX3 and infection with Helicobacter pylori in gastric epithelial dysplasia. Gut Liver (2013) 0.76
Follow-Up Study on CDX1 and CDX2 mRNA Expression in Noncancerous Gastric Mucosae After Helicobacter pylori Eradication. Dig Dis Sci (2016) 0.76
Ecological study of gastric cancer in Brazil: geographic and time trend analysis. World J Gastroenterol (2014) 0.75
Methylation-silencing RCC1 expression is associated with tumorigenesis and depth of invasion in gastric cancer. Int J Clin Exp Pathol (2015) 0.75
Loss of heterozygosity and mRNA expression at deleted in colorectal cancer gene locus in gastric cancer. World J Gastroenterol (1997) 0.75
Detectability of T-Measurable Diseases in Advanced Gastric Cancer on FDG PET-CT. Nucl Med Mol Imaging (2012) 0.75
Helicobacter pylori CagA and IL-1β Promote the Epithelial-to-Mesenchymal Transition in a Nontransformed Epithelial Cell Model. Gastroenterol Res Pract (2016) 0.75
Embryonic reversions and lineage infidelities in tumour cells: genome-based models and role of genetic instability. Int J Exp Pathol (2005) 0.75
Microsatellite instability in Korean patients with gastric adenocarcinoma. Korean J Intern Med (1997) 0.75
Telomere length is correlated with mitochondrial DNA copy number in intestinal, but not diffuse, gastric cancer. Oncol Lett (2017) 0.75
Grading and classification of chronic gastritis: one American response to the Sydney system. Gastroenterology (1992) 3.99
Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol (1988) 1.56
bcl-2 and p53 immunophenotypes in pre-invasive, early and advanced oesophageal squamous cancer. Histopathology (1997) 1.43
Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype. Cancer (1999) 1.31
Origin of spurious multiple bands in the amplification of microsatellite sequences. Mol Pathol (1999) 1.18
Fez1/lzts1 alterations in gastric carcinoma. Clin Cancer Res (2001) 1.17
The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with a cardiac location. Mol Pathol (2000) 0.94
Lack of p53 and ras mutations in Helicobacter hepaticus-induced liver tumors in A/JCr mice. Carcinogenesis (1997) 0.85
p53 alterations but no human papillomavirus infection in preinvasive and advanced squamous esophageal cancer in Italy. Cancer Epidemiol Biomarkers Prev (1997) 0.84
p16/CDKN2 alterations and pRb expression in oesophageal squamous carcinoma. Mol Pathol (1998) 0.84
Comparison of the polymorphic regions of the cytochrome P450 CYP2E1 gene of humans and patas and cynomolgus monkeys. Carcinogenesis (1999) 0.83
Cadmium suppresses apoptosis induced by chromium. J Toxicol Environ Health A (1998) 0.82
Immunohistochemical evidence of p53 overexpression in gastric epithelial dysplasia. Cancer Epidemiol Biomarkers Prev (1993) 0.81
Diet, Helicobacter pylori, and p53 mutations in gastric cancer: a molecular epidemiology study in Italy. Cancer Epidemiol Biomarkers Prev (1997) 0.80
Microsatellite instability is infrequent in azoxymethane-induced rat intestinal tumors: An assessment by capillary electrophoresis. Toxicol Appl Pharmacol (1999) 0.80
Heterozygous inactivation of TGF-beta1 increases the susceptibility to chemically induced mouse lung tumorigenesis independently of mutational activation of K-ras. Toxicol Lett (2001) 0.78
Nickel(II) acetate-treated Chinese hamster ovary cells differentially express Vimentin, hSNF2H homologue, and H ferritin. Biochem Biophys Res Commun (1999) 0.78
K-ras mutations in mouse lung tumors of extreme age: independent of paternal preconceptional exposure to chromium(III) but significantly more frequent in carcinomas than adenomas. Mutat Res (2001) 0.77
Presence of potential nickel-responsive element(s) in the mouse MTH1 promoter. Ann Clin Lab Sci (2001) 0.77
Ki-ras and the characteristics of mouse lung tumors. Mol Carcinog (2000) 0.76
Microsatellite instability and gastric cancer subtypes. Hum Pathol (1999) 0.76
Nonradioactive mRNA differential display in polyacrylamide mini-gels. Res Commun Mol Pathol Pharmacol (1999) 0.75